Researchers propose key elements of antimicrobial stewardship for hospitals worldwide

Antimicrobial stewardship programs (ASPs) in hospitals play a vital role in managing the threat of antibiotic resistance. To be of maximum effectiveness, essential elements of ASP programs need to be identified and standardized. Previous efforts in identifying the key components of ASPs have been confined to high-income countries. In a study to be published in the journal Clinical Microbiology and Infection, researchers identify essential elements of ASPs that could be applicable to hospitals in both high-income and low-income countries.

Researchers from Center for Disease Dynamics, Economics & Policy (CDDEP) and the Université de Lorraine in France conducted the study with the help of 15 experts from 13 countries in six continents. Through a consensus process, seven core elements that included 29 checklist items were identified. The seven core elements - leadership commitment, accountability, drug expertise, action, tracking, reporting, and education - are relevant across resource-rich and resource-limited settings. The researchers concluded that the next step should be to evaluate these core elements in a range of geographic and resource settings with broader stakeholder groups.

"An agreement of this nature will make a major contribution to slowing the spread of antibiotic resistance," said CDDEP fellow and study co-author Sumanth Gandra. "It will also facilitate the development of each nation's antimicrobial stewardship guidelines, especially in low income countries."

"With standardized ASP guidelines, analysis and evaluation of the programs will also be possible, which is an essential part of fine-tuning the practices and learning from one another," according to Celine Pulcini of the Université de Lorraine.

Pulcini C, Binda F, Lamkang AS, Trett A, Charani E, Goff DA, Harbarth S, Hinrichsen SL, Levy-Hara G, Mendelson M, Nathwani D, Gunturu R, Singh S, Srinivasan A, Thamlikitkul V, Thursky K, Vlieghe E, Wertheim H, Zeng M, Gandra S, Laxminarayan R.
Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach.
Clinical Microbiology and Infection, (2018). doi: 10.1016/j.cmi.2018.03.033.

Most Popular Now

Cannabis extract helps reset brain function in psy…

Research from King's College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psyc...

For first time in 40 years, cure for acute leukemi…

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefitted from new treatments, there has been no encouraging news for most leukemi...

Consuming milk at breakfast lowers blood glucose t…

A change in breakfast routine may provide benefits for the management of type 2 diabetes, according to a new study published in the Journal of Dairy Science. H. Douglas G...

New cancer treatment uses enzymes to boost immune …

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy. The enzyme, PEG-KYNase, does not directly kill can...

Bayer accelerates six new startups

Changing the experience of health: that's the focus of the six startups which the Bayer G4A team has included in the Accelerator program this year. The young companies fr...

Novartis receives European Commission approval of …

Novartis today announced that the European Commission (EC) has approved Kymriah® (tisagenlecleucel, formerly CTL019). The approved indications are for the treatment of pe...

Shire completes sale of oncology franchise

Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 billion. The franchise includes the...

Bristol-Myers Squibb - Pfizer Alliance ACROPOLIS™ …

The Bristol-Myers Squibb-Pfizer Alliance will present 15 Eliquis® (apixaban) posters at the ESC Congress 2018 held in Munich, Germany, August 25-29, 2018. Nine of the pos...

Antioxidant reduces risk for second heart attack, …

Doctors have long known that in the months after a heart attack or stroke, patients are more likely to have another attack or stroke. Now, a paper in the Journal of the A...

SOLAR-1 trial of Novartis investigational alpha-sp…

Novartis today announced the global Phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) has met the primary endpoint s...

Novartis to divest the Sandoz US dermatology busin…

Novartis today announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids po...

New tablet production facility in Ingelheim: Cente…

Boehringer Ingelheim held a groundbreaking ceremony for the construction of a new production facility for innovative drugs. This new Solids Launch facility will focus on ...